Ahlering T E, Weintraub P, Skinner D G
Department of Surgery (Urology), University of Southern California, Los Angeles.
J Urol. 1988 Dec;140(6):1397-9. doi: 10.1016/s0022-5347(17)42054-4.
Historically, survival of patients with adult pelvic sarcoma of the bladder and prostate has been poor. Between November 1974 and November 1984 we treated 11 patients with leiomyosarcoma: 7 with primary bladder and 4 with prostate tumors. Patients with nonbulky disease underwent surgical resection and were observed if the margins and nodes were negative. Patients with positive surgical margins or nodes were treated adjunctively with external beam radiotherapy, 4,500 to 5,000 rad, and chemotherapy. Patients with bulky disease were treated with preoperative chemotherapy with or without radiotherapy followed by an exenterative operation. Of the 11 patients 9 are without evidence of disease with a mean followup of 61 months (range 35 to 96 months). One patient was lost to followup after 4 months and 1 died of disease after 11 months. Three patients with rhabdomyosarcoma were treated and 1 had no evidence of disease 24 months after therapy. Two patients died at 4 and 18 months.
从历史上看,成年膀胱和前列腺盆腔肉瘤患者的生存率一直很低。1974年11月至1984年11月期间,我们治疗了11例平滑肌肉瘤患者:7例原发性膀胱肿瘤患者和4例前列腺肿瘤患者。对于病灶不大的患者,若切缘和淋巴结阴性,则进行手术切除并观察。手术切缘阳性或淋巴结阳性的患者接受4500至5000拉德的体外束放疗及化疗作为辅助治疗。病灶较大的患者接受术前化疗,可联合或不联合放疗,然后进行盆腔脏器清除术。11例患者中,9例无疾病证据,平均随访61个月(范围35至96个月)。1例患者在4个月后失访,1例患者在11个月后死于疾病。3例横纹肌肉瘤患者接受了治疗,1例在治疗后24个月无疾病证据。2例患者分别在4个月和18个月时死亡。